( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Dr. Hitesh Kumar*, Dr. Vijay Thakur, Dr. Sushma Makhaik, Dr. Sanjay Mahajan and Dr. Esha Singh


Background: Role of amylase and lipase in the diagnosis and prognosis of acute pancreatitis has frequently been the subject of confusion and controversy. A three fold rise in serum amylase and lipase is required for diagnosis of acute pancreatitis. However acute pancreatitis can occur with normal levels of amylase and lipase confirmed by computed tomography. Methods: In this study, total 40 patients were included who presented with clinical suspicion of acute pancreatitis. These patients were evaluated clinically, biochemical analysis was done and then CECT was done in all cases after 72 hours. CECT findings were evaluated in all the patients. Modified CT severity index was calculated in each patient and its correlation between serum amylase and lipase values was evaluated. CECT findings in lipase negative and lipase positive patients were compared. Patients were followed up for complications at two months interval. Results: 29.8% of the study population (Lip−) had less than three fold rise in serum lipase levels at presentation despite abdominal pain and signs of Acute pancreatitis on CECT. Extra-pancreatic findings such as pleural effusion and Ascites were more in lipase positive patients. On follow up, complications were significantly more in lipase positive group as compared to lipase negative group (19.2% vs 9.1%). Conclusion: A significant subset of patients with clinically suspected acute pancreatitis, without threefold increase in lipase levels on admission can also have evidence of acute pancreatitis on imaging. Without CECT, this substantial subset of patients would remain under-diagnosed. CECT is absolutely mandatory in subset of patients with less than three fold rise in serum lipase for correct early diagnosis of acute pancreatitis and thereby reducing mortality and morbidity.

Keywords: MDCT; Acute pancreatitis; serum lipase; less than three fold rise.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 May 2024 Issue has been Published, Kindly check it on


    MAY 2024 issue has been successfully launched on MAY 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia